Mohammed Vi University Hospital
Clinical trials sponsored by Mohammed Vi University Hospital, explained in plain language.
-
Heart attack drug shows promise for Non-Diabetics
Disease control CompletedThis completed study tested whether SGLT2 inhibitors (dapagliflozin or empagliflozin), taken daily, can reduce heart failure hospitalizations, repeat heart attacks, and death in 450 non-diabetic patients who had a heart attack treated with stenting. Participants received the drug…
Sponsor: Mohammed VI University Hospital • Aim: Disease control
Last updated Jun 26, 2026 17:05 UTC
-
What drives eyelid cancer in eastern morocco? a new study digs into the data
Knowledge-focused CompletedThis study reviews the medical records of 20 people treated for eyelid carcinomas at a hospital in eastern Morocco. Researchers are examining patient characteristics, tumor types, and surgical approaches to better understand how these cancers present and are managed in this regio…
Sponsor: Mohammed VI University Hospital • Aim: Knowledge-focused
Last updated Jul 25, 2026 00:00 UTC